Switch to:
Also traded in: Germany, Israel

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt No Debt
PHMD's Cash-to-Debt is ranked higher than
61% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. PHMD: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
PHMD' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.08  Med: 2.63 Max: No Debt
Current: No Debt
Equity-to-Asset 0.05
PHMD's Equity-to-Asset is ranked lower than
94% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. PHMD: 0.05 )
Ranked among companies with meaningful Equity-to-Asset only.
PHMD' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.08  Med: 0.7 Max: 0.91
Current: 0.05
-0.08
0.91
Piotroski F-Score: 4
Altman Z-Score: -11.65
Beneish M-Score: -6.26
WACC vs ROIC
13.24%
-984.64%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -30.28
PHMD's Operating Margin % is ranked lower than
76% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. PHMD: -30.28 )
Ranked among companies with meaningful Operating Margin % only.
PHMD' s Operating Margin % Range Over the Past 10 Years
Min: -53  Med: -17.02 Max: 25.93
Current: -30.28
-53
25.93
Net Margin % -33.36
PHMD's Net Margin % is ranked lower than
76% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. PHMD: -33.36 )
Ranked among companies with meaningful Net Margin % only.
PHMD' s Net Margin % Range Over the Past 10 Years
Min: -91.38  Med: -26.33 Max: 16.56
Current: -33.36
-91.38
16.56
ROE % -441.00
PHMD's ROE % is ranked lower than
97% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. PHMD: -441.00 )
Ranked among companies with meaningful ROE % only.
PHMD' s ROE % Range Over the Past 10 Years
Min: -441  Med: -23.91 Max: 55.77
Current: -441
-441
55.77
ROA % -45.92
PHMD's ROA % is ranked lower than
90% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. PHMD: -45.92 )
Ranked among companies with meaningful ROA % only.
PHMD' s ROA % Range Over the Past 10 Years
Min: -59.58  Med: -16.1 Max: 22.6
Current: -45.92
-59.58
22.6
ROC (Joel Greenblatt) % -755.61
PHMD's ROC (Joel Greenblatt) % is ranked lower than
86% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. PHMD: -755.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PHMD' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -755.61  Med: -38.36 Max: 163.98
Current: -755.61
-755.61
163.98
3-Year Revenue Growth Rate -44.70
PHMD's 3-Year Revenue Growth Rate is ranked lower than
88% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. PHMD: -44.70 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PHMD' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -8.2 Max: 139.9
Current: -44.7
0
139.9
GuruFocus has detected 3 Warning Signs with PhotoMedex Inc $PHMD.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PHMD's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

PHMD Guru Trades in Q2 2016

Jim Simons 874,200 sh (+3.04%)
» More
Q3 2016

PHMD Guru Trades in Q3 2016

Jim Simons 187,300 sh (+7.13%)
» More
Q4 2016

PHMD Guru Trades in Q4 2016

Jim Simons 247,880 sh (+32.34%)
» More
Q1 2017

PHMD Guru Trades in Q1 2017

Jim Simons 145,500 sh (-41.30%)
» More
» Details

Insider Trades

Latest Guru Trades with PHMD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:NAS:SSH, OTCPK:PBIO, NAS:AHPI, NAS:MDGS, AMEX:NSPR, OTCPK:MPHMF, OTCPK:IGNG, AMEX:XTNT, OTCPK:ACXA, OTCPK:PYNGF, OTCPK:VYCO, NAS:AVGR, OTCPK:NUMD, OTCPK:EQUR, OTCPK:ACAR, OTCPK:VRSEF, OTCPK:ESMC, NAS:DYNT, AMEX:MICR, OTCPK:BIAD » details
Traded in other countries:LA9N.Germany, PHMD.Israel,
Headquarter Location:USA
PhotoMedex Inc is a skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers, and provides proprietary products and services that address skin diseases.

PhotoMedex Inc was originally formed in Delaware in 1980 and re-incorporated in Nevada on December 30, 2010. The Company is a skin health company providing integrated disease management and aesthetic solutions to dermatologists, professional aestheticians and consumers. It provides proprietary products and services that address skin diseases and conditions including psoriasis, vitiligo, acne and photo damage. The physician market provides the platform to expand its skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. Its professional product line also offers for acne clearance, skin tightening, psoriasis care and hair removal sold to physician clinics and spas. It is also engaged in the development, manufacture and sale of surgical products, including proprietary free-beam and Contact Laser Systems for surgery. The Company operates in three business segments; Consumer segment, Physician Recurring segment and Professional segment. It emphasizes the development of physician-endorsed skin care products based on science. It has added a range of home-use devices under the no!no! brand, for various indications including hair removal, acne treatment, skin rejuvenation, and lower back pain. Its no!no! hair removal products are built upon its proprietary heat-based Thermicon brand technology to address consumer concerns over perceived limitations of existing hair removal products, including safety and pain, and to overcome inherent limitations of light-based hair removal solutions. The Company competes with small, closely held, specialized aesthetic device companies, such as Dezac Group, Home Skinovations Ltd., TRIA Beauty, Inc. and LumaTherm Inc, and several public companies, such as Syneron Medical Ltd, Cynosure Inc., and Valeant Pharmaceuticals, Inc. The Company's products and research and development activities are regulated by numerous governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies.

Ratios

vs
industry
vs
history
PB Ratio 9.07
PHMD's PB Ratio is ranked lower than
99.99% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. PHMD: 9.07 )
Ranked among companies with meaningful PB Ratio only.
PHMD' s PB Ratio Range Over the Past 10 Years
Min: 0.23  Med: 1.51 Max: 12.38
Current: 9.07
0.23
12.38
PS Ratio 0.20
PHMD's PS Ratio is ranked higher than
98% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. PHMD: 0.20 )
Ranked among companies with meaningful PS Ratio only.
PHMD' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.56 Max: 2.76
Current: 0.2
0.08
2.76
EV-to-EBIT -0.36
PHMD's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. PHMD: -0.36 )
Ranked among companies with meaningful EV-to-EBIT only.
PHMD' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.1  Med: -2.3 Max: 21.7
Current: -0.36
-80.1
21.7
EV-to-EBITDA -0.37
PHMD's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. PHMD: -0.37 )
Ranked among companies with meaningful EV-to-EBITDA only.
PHMD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -103.7  Med: -3 Max: 57571
Current: -0.37
-103.7
57571
Current Ratio 0.74
PHMD's Current Ratio is ranked lower than
90% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. PHMD: 0.74 )
Ranked among companies with meaningful Current Ratio only.
PHMD' s Current Ratio Range Over the Past 10 Years
Min: 0.74  Med: 2.01 Max: 9.54
Current: 0.74
0.74
9.54
Quick Ratio 0.74
PHMD's Quick Ratio is ranked lower than
94% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. PHMD: 0.74 )
Ranked among companies with meaningful Quick Ratio only.
PHMD' s Quick Ratio Range Over the Past 10 Years
Min: 0.47  Med: 1.36 Max: 8.92
Current: 0.74
0.47
8.92
Days Inventory 639.35
PHMD's Days Inventory is ranked lower than
88% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. PHMD: 639.35 )
Ranked among companies with meaningful Days Inventory only.
PHMD' s Days Inventory Range Over the Past 10 Years
Min: 145.69  Med: 183.92 Max: 639.35
Current: 639.35
145.69
639.35
Days Sales Outstanding 17.78
PHMD's Days Sales Outstanding is ranked higher than
94% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. PHMD: 17.78 )
Ranked among companies with meaningful Days Sales Outstanding only.
PHMD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.07  Med: 42.48 Max: 68.17
Current: 17.78
17.07
68.17
Days Payable 272.27
PHMD's Days Payable is ranked higher than
89% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. PHMD: 272.27 )
Ranked among companies with meaningful Days Payable only.
PHMD' s Days Payable Range Over the Past 10 Years
Min: 62.12  Med: 112.18 Max: 300.09
Current: 272.27
62.12
300.09

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -4.90
PHMD's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. PHMD: -4.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PHMD' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -132.3  Med: -18.6 Max: 0
Current: -4.9
-132.3
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 9.06
PHMD's Price-to-Tangible-Book is ranked lower than
99.99% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. PHMD: 9.06 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PHMD' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.19  Med: 4.37 Max: 18.88
Current: 9.06
1.19
18.88
Price-to-Intrinsic-Value-Projected-FCF 0.25
PHMD's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
99% of the 129 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. PHMD: 0.25 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PHMD' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.09  Med: 1.56 Max: 42.63
Current: 0.25
0.09
42.63
Price-to-Median-PS-Value 0.35
PHMD's Price-to-Median-PS-Value is ranked higher than
95% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. PHMD: 0.35 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PHMD' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.16  Med: 2.69 Max: 762.87
Current: 0.35
0.16
762.87
Earnings Yield (Greenblatt) % -279.37
PHMD's Earnings Yield (Greenblatt) % is ranked lower than
99.99% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. PHMD: -279.37 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PHMD' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -299.14  Med: 10.9 Max: 52.6
Current: -279.37
-299.14
52.6

More Statistics

Revenue (TTM) (Mil) $30.70
EPS (TTM) $ -2.44
Beta0.90
Short Percentage of Float10.22%
52-Week Range $0.90 - 5.60
Shares Outstanding (Mil)5.24

Analyst Estimate

Dec17
Revenue (Mil $)
EPS ($) -0.55
EPS without NRI ($) -0.55
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for PHMD

Headlines

Articles On GuruFocus.com
First Capital Contributes Real Estate Interests To PhotoMedex May 22 2017 
First Capital Real Estate Trust Incorporated And PhotoMedex, Inc. Announce Entry Into Contribution A Mar 31 2017 
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016 
Weekly CEO Sells Highlight: Cadence Design Systems Inc., Nektar Therapeutics Inc., Netflix Inc., Pho Sep 27 2015 
Weekly 3-Year Low Highlights: GES, QLGC, NPK, PHMD, FHCO Aug 31 2014 
4 Attractive Small-Cap Growth + Value Stocks You Have Never Heard Of Apr 16 2014 
Weekly CEO Sells Highlight: Tiffany & Co, Coleman Cable Inc, PhotoMedex Inc, Imax Corporation Jun 23 2013 
Is Photomedex Poised for a Short Squeeze? Apr 16 2013 
Weekly CEO Sells Highlight: Starbucks Corporation, Applied Materials Inc, PhotoMedex Inc, Gap Inc. Mar 10 2013 
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD Jan 27 2013 

More From Other Websites
First Capital Contributes Real Estate Interests To PhotoMedex May 22 2017
PhotoMedex, Inc. :PHMD-US: Earnings Analysis: Q4, 2016 By the Numbers : April 6, 2017 Apr 06 2017
First Capital Real Estate Trust Incorporated And PhotoMedex, Inc. Announce Entry Into Contribution... Mar 31 2017
Wayne infomercial company completes 2 'transformative' deals Jan 27 2017
PhotoMedex, Inc. :PHMD-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 Nov 18 2016
ICTV Brands Inc. to Report Third Quarter 2016 Financial Results on November 10, 2016 Nov 03 2016
$9.5M deal: Local company to buy no!no! hair removal brand Oct 06 2016
ICTV Brands, Inc. Announces Definitive Agreement to Acquire the no!no! Hair Removal Brand Oct 05 2016
PhotoMedex, Inc. :PHMD-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 Jun 22 2016
ETF’s with exposure to PhotoMedex, Inc. : June 20, 2016 Jun 20 2016
ETF’s with exposure to PhotoMedex, Inc. : April 29, 2016 Apr 29 2016
PhotoMedex, Inc. :PHMD-US: Earnings Analysis: Q4, 2015 By the Numbers Apr 14 2016
4 Small Cap Stocks That Are Making Big Moves Today Feb 22 2016
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016
PhotoMedex, Inc. Earnings Q2, 2015 Oct 01 2015
Weekly CEO Sells Highlight: Cadence Design Systems Inc., Nektar Therapeutics Inc., Netflix Inc. ... Sep 27 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)